Moderna (MRNA) News Today $33.64 -0.64 (-1.87%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$33.57 -0.07 (-0.21%) As of 07/11/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Moderna Down Today?Toggle Visibility of Why Is Moderna Down Today?Moderna, Inc. (MRNA) shares have risen on multiple regulatory and clinical updates bolstering its COVID-19 and next-generation vaccine pipeline. Positive Sentiment: FDA grants full approval for Spikevax in children aged six months to 11 years at increased risk for COVID-19, expanding the addressable pediatric market MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients Positive Sentiment: Spikevax receives full U.S. FDA approval for at-risk children six months and older, replacing prior EUA status Moderna gets full US approval for COVID vaccine in children 6 months and older Positive Sentiment: Phase III trial shows mRNA-1010 flu vaccine meets efficacy goals in adults aged 50+, signaling potential for a new seasonal vaccine franchise Moderna’s mRNA-1010 Flu Vaccine Meets Efficacy Goals in Phase III Trial of Adults 50+ Positive Sentiment: Analysis names Moderna as a high-upside buying opportunity after its share price pullback, citing long-term vaccine pipeline potential This Former Meme Stock, Down 93%, is a High-Upside Buy Right Now Neutral Sentiment: Moderna schedules its Q2 2025 earnings release and conference call for August 1, giving investors a date to assess upcoming financial results Moderna, Inc.: Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025 Neutral Sentiment: Short interest remains negligible with zero shares reported, indicating minimal bearish positioning despite recent volatility Negative Sentiment: Pfizer and BioNTech appeal in U.K. court to overturn Moderna’s COVID-19 vaccine patent win, potentially threatening intellectual property exclusivity Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win Posted 1+ days agoAI Generated. May Contain Errors. MRNA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Moderna (NasdaqGS:MRNA) Added to Russell Midcap Indexes3 hours ago | finance.yahoo.comU.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To KnowJuly 11 at 4:39 PM | msn.comModerna, Inc.: Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025July 11 at 11:37 AM | finanznachrichten.deModerna gets full FDA approval for kids COVID-19 vaccineJuly 11 at 11:37 AM | msn.comThis Former Meme Stock, Down 93%, is a High-Upside Buy Right NowJuly 11 at 10:44 AM | 247wallst.comModerna gets full US approval for COVID shot in at-risk children 6 months and olderJuly 11 at 6:37 AM | msn.comFDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 MonthsJuly 10 at 2:13 PM | benzinga.comModerna wins full FDA approval for COVID shot in childrenJuly 10 at 10:22 AM | msn.com45,064 Shares in Moderna, Inc. (NASDAQ:MRNA) Purchased by Financial Gravity Asset Management Inc.July 10 at 9:09 AM | marketbeat.comModerna gets full US approval for COVID vaccine in children 6 months and olderJuly 10 at 8:33 AM | reuters.comPfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent winJuly 10 at 7:18 AM | reuters.comMoloney Securities Asset Management LLC Has $1.42 Million Stake in Moderna, Inc. (NASDAQ:MRNA)July 10 at 7:15 AM | marketbeat.comTeacher Retirement System of Texas Sells 11,886 Shares of Moderna, Inc. (NASDAQ:MRNA)July 10 at 3:50 AM | marketbeat.comModerna (MRNA) Jumps 8.8% on COVID-19 Support from Medical OrganizationsJuly 9 at 7:19 PM | finance.yahoo.comS&P 500 Gains & Losses Today: FICO Shares Plummet; Moderna Stock RisesJuly 8, 2025 | msn.comThe Next Moderna? This Clinical-Stage Biotech Has Breakout Potential.July 8, 2025 | msn.comS&P 500 Gains and Losses Today: FICO Shares Plummet; Moderna Stock RisesJuly 8, 2025 | investopedia.comModerna (NASDAQ:MRNA) Shares Up 8.4% - Time to Buy?July 8, 2025 | marketbeat.comWilliam Blair Remains a Hold on Moderna (MRNA)July 7, 2025 | theglobeandmail.comModerna, Inc. (NASDAQ:MRNA) Shares Sold by Harel Insurance Investments & Financial Services Ltd.July 6, 2025 | marketbeat.comQuattro Financial Advisors LLC Reduces Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)July 5, 2025 | marketbeat.com2 Beaten-Down Stocks to Buy and HoldJuly 5, 2025 | fool.comWhere Will Moderna Be in 10 Years?July 5, 2025 | fool.comNew York State Teachers Retirement System Sells 15,203 Shares of Moderna, Inc. (NASDAQ:MRNA)July 5, 2025 | marketbeat.comWhy Moderna Stock Was So Healthy This WeekJuly 4, 2025 | fool.comModerna, Inc. (NASDAQ:MRNA) Receives $46.61 Average PT from BrokeragesJuly 4, 2025 | americanbankingnews.comModerna Target of Unusually High Options Trading (NASDAQ:MRNA)July 4, 2025 | americanbankingnews.comModerna (NasdaqGS:MRNA) Joins Russell Midcap Indices In Late June 2025July 3, 2025 | finance.yahoo.comRFK Jr. Just Did The Unexpected. He Helped Moderna.July 2, 2025 | investors.comInvestors Purchase Large Volume of Call Options on Moderna (NASDAQ:MRNA)July 2, 2025 | marketbeat.comModerna's new flu shot shows strong results in older adultsJuly 2, 2025 | msn.comModerna's flu-COVID combo shot will test RFK Jr.'s vaccine regulatorsJuly 2, 2025 | msn.comModerna’s New Flu Shot Shows Strong Results in Older AdultsJuly 1, 2025 | usnews.com13,644 Shares in Moderna, Inc. (NASDAQ:MRNA) Acquired by Diversified Trust CoJuly 1, 2025 | marketbeat.comSpire Wealth Management Sells 17,807 Shares of Moderna, Inc. (NASDAQ:MRNA)July 1, 2025 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Given Average Rating of "Hold" by BrokeragesJuly 1, 2025 | marketbeat.comModerna’s mRNA flu shot outperforms current standard at Phase IIIJune 30, 2025 | finance.yahoo.comExperimental Moderna flu shot more effective than approved vaccine, company saysJune 30, 2025 | msn.comModerna Stock Is Climbing on Trial Data. A Flu-Covid Vaccine Isn’t a Sure Thing.June 30, 2025 | msn.comTop Stock Movers Now: Hewlett Packard Enterprise, Moderna, Tesla, and MoreJune 30, 2025 | investopedia.comModerna Shares Jump With Positive Test Results for MRNA Flu VaccineJune 30, 2025 | wsj.comModerna's influenza vaccine superior to licensed shot in studyJune 30, 2025 | reuters.comModerna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shotJune 30, 2025 | cnbc.comWhat is myocarditis? What to know about heart risk warning related to COVID-19 vaccinesJune 27, 2025 | usatoday.comCOVID Vaccines Heart Risk Warning Update Issued by FDAJune 27, 2025 | msn.comFDA expands warning on rare heart risk linked to Pfizer and Moderna COVID vaccinesJune 26, 2025 | msn.comKentucky Retirement Systems Insurance Trust Fund Purchases New Position in Moderna, Inc. (NASDAQ:MRNA)June 26, 2025 | marketbeat.comModerna (MRNA): Buy, Sell, or Hold Post Q1 Earnings?June 25, 2025 | msn.comWealthquest Corp Invests $1.04 Million in Moderna, Inc. (NASDAQ:MRNA)June 25, 2025 | marketbeat.comModerna RSV Vaccine Gains Expanded FDA Approval for Younger AdultsJune 25, 2025 | msn.com Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address MRNA Media Mentions By Week MRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.720.99▲Average Medical News Sentiment MRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼2025▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRISPR Therapeutics News CureVac News Robinhood Markets News Novavax News Ocugen News Tesla News Johnson & Johnson News Merck & Co., Inc. News Pfizer News argenex News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRNA Stock Alerts